Prognostic impact of heart failure admission in survivors of acute myocardial infarction

Author:

Takeuchi Satoshi1ORCID,Honda Satoshi2,Nishihira Kensaku3,Kojima Sunao4,Takegami Misa56,Asaumi Yasuhide2,Saji Mike7,Yamashita Jun8,Hibi Kiyoshi9,Takahashi Jun1,Sakata Yasuhiko2,Takayama Morimasa7,Sumiyoshi Tetsuya7,Ogawa Hisao10,Kimura Kazuo9,Yasuda Satoshi1,

Affiliation:

1. Department of Cardiovascular Medicine Tohoku University Sendai Japan

2. Department of Cardiovascular Medicine National Cerebral and Cardiovascular Centre Suita Japan

3. Department of Cardiovascular Medicine Miyazaki Medical Association Hospital Miyazaki Japan

4. Department of Internal Medicine Sakurajyuji Yatsushiro Rehabilitation Hospital Yatsushiro Japan

5. Department of Preventive Medicine and Epidemiologic Informatics National Cerebral and Cardiovascular Centre Suita Japan

6. Department of Public Health and Health Policy, Graduate School of Medicine The University of Tokyo Tokyo Japan

7. Department of Cardiology Sakakibara Heart Institute Fuchu Japan

8. Department of Cardiology Tokyo Medical University Hospital Tokyo Japan

9. Department of Cardiovascular Medicine Yokohama City University Medical Centre Yokohama Japan

10. Kumamoto University Kumamoto Japan

Abstract

AbstractAimsThe incidence and prognosis of symptomatic heart failure following acute myocardial infarction (AMI) in the primary percutaneous coronary intervention era have rarely been reported in the literature. This study aimed to (i) determine the incidence of heart failure admission among AMI survivors, (ii) compare 1 year outcomes between patients with heart failure admission and those without, and (iii) identify the independent risk factors associated with heart failure admission.Methods and resultsThe Japan Acute Myocardial Infarction Registry is a prospective multicentre registry from which data on consecutively enrolled patients with AMI from 50 institutions between 2015 and 2017 were obtained. Among the 3411 patients enrolled, 3226 who survived until discharge were included in this study. The primary endpoint was all‐cause mortality. The secondary endpoints were major adverse cardiovascular events (defined as cardiovascular mortality, non‐fatal myocardial infarction, or non‐fatal cerebral infarction) and major bleeding events corresponding to Bleeding Academic Research Consortium Type 3 or 5. Clinical outcomes were compared between the patients who were and were not admitted for heart failure. Over a median follow‐up of 12 months, 124 patients (3.8%) were admitted due to heart failure. Independent risk factors for heart failure admission included older age, female sex, Killip class ≥2 on admission, left ventricular ejection fraction <40%, estimated glomerular filtration rate ≤30 mL/min/1.73 m2, a history of malignancy, and non‐use of angiotensin‐converting enzyme inhibitors at discharge. The cumulative incidence of all‐cause mortality was significantly higher in the heart failure admission group than in the no heart failure admission group (11.3% vs. 2.5%, P < 0.001). The rates of major adverse cardiovascular events (16.9% vs. 2.7%, P < 0.001) and major bleeding (6.5% vs. 1.6%, P < 0.001) were significantly higher in the heart failure admission group. Heart failure admission was associated with a higher risk of all‐cause mortality, even after adjusting for potential confounders (adjusted hazard ratio: 2.41, 95% confidence interval: 1.33–4.39, P = 0.004).ConclusionsUtilizing real‐world data of the contemporary percutaneous coronary intervention era from the Japan Acute Myocardial Infarction Registry database, this study demonstrates that the heart failure admission of AMI survivors was significantly associated with higher all‐cause mortality rates.

Funder

Daiichi-Sankyo

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3